First guidelines for the treatment of LM disease issued by SOLACI and SIAC

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/47/51/05/475105a5-3620-0e30-29c8-d1e9b61ed7b7/mza_6886755722591689747.jpeg/600x600bb.jpg

PCR Perspectives

PCR

33 episodes

4 days ago

Stay at the forefront of interventions for valvular heart disease, coronary, and structural interventions with expert insights and perspectives. These interviews explore the techniques, tools, and key topics shaping the ever-evolving field of interventional cardiology

Hosted on Acast. See acast.com/privacy for more information.

All content for PCR Perspectives is the property of PCR and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Hosted on Acast. See acast.com/privacy for more information.

Medicine

Education,

Health & Fitness

https://assets.pippa.io/shows/67bc9816b63437eabc3c8036/1740414554289-af656d96-6b01-43c9-9fcb-9dabd8a345f4.jpeg

First guidelines for the treatment of LM disease issued by SOLACI and SIAC

PCR Perspectives

5 minutes 24 seconds

3 months ago

First guidelines for the treatment of LM disease issued by SOLACI and SIAC

Cleverson Zukowski and Pablo Lamelas take a moment during #europcr 2025 to shed light on a major regional milestone: the first-ever guidelines for the treatment of left main disease, issued jointly by the Latin American Society of Interventional Cardiology (SOLACI) and the Interamerican Society of Cardiology (SIAC).

Why were these guidelines created specifically for Latin America? What are their key recommendations? And how can they be applied in day-to-day practice, especially when deciding between PCI and surgery?

Tune in to hear how these guidelines reflect the region’s unique healthcare challenges and may help tailor treatment to the specific needs of Latin American patients.

Hosted on Acast. See acast.com/privacy for more information.